Javara, a leading integrated research organization (IRO) delivering clinical trials at the point of care through strategic partnership with healthcare organizations, announced it has secured a significant growth investment in Series C funding from earlier and new community-based investors.

Javara是一家领先的综合研究组织（IRO），通过与医疗保健机构的战略合作，在诊疗点开展临床试验。该公司宣布已获得来自早期和新的社区投资者的C轮融资，这是一笔重要的增长投资。

This funding will support the expansion of both current and new healthcare partnerships and allow the company to grow into new therapeutic specialties such as Oncology, CNS, and Neurology through localized clinical research collaborations that increase patient access and amplify geographic footprint..

这笔资金将支持当前和新的医疗保健合作伙伴关系的扩展，并通过本地化的临床研究合作，增加患者获取渠道并扩大地理覆盖范围，使公司能够进军肿瘤学、中枢神经系统和神经学等新的治疗领域。